Panagora Asset Management Inc Solid Biosciences Inc. Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.74 - $1.79 $90,129 - $218,016	-121,797 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$1.69 - $2.46 $3,496 - $5,089	2,069 Added 1.73%	121,797 $213,000
Q3 2021 Nov 10, 2021	BUY	$2.38 - $3.77 $283,222 - $448,633	119,001 Added 16368.78%	119,728 $286,000
Q2 2021 Aug 11, 2021	SELL	$3.49 - $5.51 $2,519 - $3,978	-722 Reduced 49.83%	727 $3,000
Q4 2020 Feb 10, 2021	BUY	$3.08 - $7.79 $2,239 - $5,663	727 Added 100.69%	1,449 $11,000
Q3 2020 Nov 13, 2020	BUY	$2.02 - $3.08 $1,458 - $2,223	722 New	722 $1,000
Q2 2020 Aug 12, 2020	SELL	$2.1 - $3.42 $31,233 - $50,865	-14,873 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$2.31 - $4.43 $34,356 - $65,887	14,873 New	14,873 $36,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $22.7M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.